Saturday, August 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Maintaining Neutral Rating with Raised Price Target for SM Energy

Elaine Mendonca by Elaine Mendonca
February 26, 2024
in Breaking News
0
Renewable-energy
0
SHARES
36
VIEWS
Share on FacebookShare on Twitter

Susquehanna analyst Biju Perincheril has decided to maintain a Neutral rating on SM Energy (NYSE:SM) on February 26, 2024. However, he has raised the price target from $38 to $42, showing a more optimistic view on the stock’s potential performance. This adjustment suggests that Perincheril sees some positive developments ahead for SM Energy.

SM Stock Performance Update: Slight Decrease on February 26, 2024, but Still Strong Compared to Historical Performance

On February 26, 2024, SM stocks showed a slight decrease in performance, with the price dropping by $0.04 since the last market close. This represents a 0.10% decrease in value. The stock opened at $41.23, which was $0.19 lower than its previous close. Despite this slight dip in performance, SM is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time, and investors may still have confidence in its potential for growth. It is important for investors to closely monitor the performance of SM stocks in the coming days to see if this slight decrease is a temporary fluctuation or the start of a larger trend. Keeping an eye on market trends and news related to the company can help investors make informed decisions about buying, selling, or holding onto their SM stocks. Overall, while there was a slight decrease in SM stock performance on February 26, 2024, the stock is still showing strength compared to its historical performance. Investors should continue to stay informed and monitor the stock closely to make the best decisions for their investment portfolios.

SM Stock Performance Analysis: Revenue and Net Income Decline in 2024

On February 26, 2024, investors were closely watching the performance of SM stock after the company released its latest financial results. SM reported total revenue of $2.37 billion for the past year, a decrease of 29.32% compared to the previous year. Total revenue remained flat compared to the previous quarter, coming in at $608.73 million for Q4.

SM’s net income for the past year was reported at $817.88 million, showing a decrease of 26.45% from the previous year. Net income also held flat compared to the previous quarter, with Q4 net income coming in at $247.11 million.

Earnings per share (EPS) for SM were reported at $6.86 for the past year, representing a 23.46% decrease from the previous year. EPS remained unchanged compared to the previous quarter, with Q4 EPS reported at $2.12.

Overall, SM’s financial performance showed a decline in key metrics compared to the previous year. However, the company was able to maintain stability in its financial performance compared to the previous quarter. Investors will be monitoring future developments and announcements from SM to assess the company’s growth prospects and potential for improvement in financial performance.

Tags: SM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Enlivex Receives Regulatory Approval for Phase 12 Clinical Study on Allocetra for Knee Osteoarthritis

Finance_Fiscal (3)

Analyst Initiates Coverage on GoodRx Holdings with Outperform Rating and 8 Price Target

Biotechnology Stock Market Today (1)

Owlet Announces 9 Million Private Placement Financing Deal with Series B Preferred Stock

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com